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Abstract Eukaryotic initiation factor elF-1 was purified from 
rabbit reticnlocytes. Amino acid sequence analysis revealed that 
the protein contained a blocked amino-terminus. After cleavage 
with the endoproteinase Asp-N, three peptides were sequenced. 
The obtained partial sequences were identical to sequences of 
SUIIISO1, the human homologue of the yeast translation initia- 
tion factor SUI1. The SUI1 gene product was identified as a 
protein involved in the recognition of the protein synthesis initia- 
tion codon. A similar mode of action has been suggested for eIF-1. 
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I. Introduction 
Initiation of eukaryotic protein synthesis is mediated by at 
least 10 proteins, containing 26 peptide chains. The role of some 
initiation factors is still unclear. This is especially true for elF-1 
and elF-3, two proteins whose amino acid sequence is un- 
known. 
The single-polypeptide elF-1 stimulated mRNA and Met- 
tRNA binding to the 40S ribosomal subunit, as well as to the 
80S ribosome [14]. The dependence on elF-1 in these processes 
varied in different laboratories, reason to suggest hat elF-1 
may not be crucial for translation initiation. However, we could 
show that the binding of the second aminoacyl-tRNA complex 
to the ribosome was nearly completely dependent on elF-1 [2]. 
The observations led us to assume that elF-1 had a stabilizing 
effect on the binding of Met-tRNA, facilitating the codon- 
anticodon interaction [2]. 
Recently, a yeast protein was found to be involved in the 
interaction of the ribosome with the initiation codon, similar 
to the mode of action of elF-2 [5]. The molecular mass of this 
SUI1 protein was 12,300 Da, suggesting that SUI1 may be one 
of the small initiation factors e lF- l ,  elF-1A, or elF-5A. The 
amino acid sequence of the latter two proteins was solved and 
not similar to that of SUI1 [5,6]. 
In this paper, we purified elF-1 from rabbit reticulocyte, 
confirmed its ability to stimulate Met- tRNA binding, and se- 
quenced the cleaved protein by Edman degradation. The result- 
ing peptide sequences were found in the EMBL database, and 
corresponded to the mammalian homolog of SUI I .  
2. Materials and methods 
Reagents were purchased from the following suppliers: sodium 
dodecyl sulphate (electrophoresis grade) from Biorad; hydrogenated 
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Triton-X100 (protein grade) from Calbiochem Corp., trifluoroacetic 
acid and acetonitrile (both HPLC grade) from J.T. Baker, and 
[35S]Methionine (1300 Ci/mmol) from Amersham. Endoproteinase 
Asp-N was obtained from Boehringer Mannheim. All chemicals used 
in protein sequencing were purchased from Applied Biosystems. PVDF 
membranes (Immobilon-P) were obtained from Millipore Corp. All 
other chemicals were reagent grade quality. Milli Q water was used 
throughout. 
2.1. Purification of rabbit reticulocyte lF-1 
Two sources of elF-1 were used in this study. Ribosome-bound elF-1 
was purified from rabbit reticulocytes a  described previously [7] and 
used as a reference protein. Due to the low amount of elF-1 obtained, 
amino acid sequencing was performed on elF-I isolated from postri- 
bosomal supernatants. In this case a modified isolation procedure was 
used. After Sepharose 6B-heparin affinity chromatography [8]and 40- 
70% ammoniumsulphate pr cipitation, 414 mg of protein was subjected 
to Fast Protein Liquid Chromatography (FPLC). All FPLC columns, 
except for Q- Sepharose FF were equilibrated in20 mM HEPES-KOH 
(pH 7.6), 10% (v/v) glycerol, 100 mM KC1, 0.1 mM EDTA and 7 mM 
2-mercaptoethanol. Tris-HC1 (20 mM, pH 7.6) was used instead of 
HEPES-KOH for the Q Sepharose column. Proteins were eluted from 
the ion-exchange columns with step elution gradients of KC1. elF-1 did 
not bind to Q-Sepharose FF 16/10 and eluted between 200 and 400 mM 
KC1 from SP Sepharose FF 16/10 columns. After ~70% ammoni- 
umsulphate precipitation and dialysis of the dissolved precipitate, 32 
mg of protein was subjected to Superose 12 HR 10/30 gelfiltration, 
using 8 mg of protein per run. elF-1 eluted between 14.5 and 16.5 m[, 
comparable to cytochrome C. Finally 0.46 mg of protein containing 
elF-I was concentrated by Mono S HR 5/5 chromotography and dia- 
lysed against 20 mM HEPES-KOH (pH 7.6), 10% (v/v) glycerol, 
100 mM KAc, 0.1 mM EDTA and 1 mM DTT. Fractions were ana- 
lyzed by Fast Green staining of SDS-polyacrylamide g ls and by its 
ability to stimulate Met-tRNA binding to 40S initiation complexes. 
elF-1 activity was measured by binding of [35S]Met-tRNA to 40S initi- 
ation complexes [2] with 2.8 pg elF-2/elF-2B, 7 pg elF-3, 0.15 ,ug 
eIF-lA, and 4 pmol of [35S]methionyl-tRNA with a specific activity of 
50,000 cplrdpmol. The assays were performed without he addition of 
mRNA or AUG. 
2.2. Tricine-SDS-PA GE and electroblotting 
20 pg of elF-l, purified as described above, was subjected to discon- 
tinuous SDS-polyacrylamide g lelectrophoresis [9]. The gel was pre- 
electrophoresed with 0.5 M Tris-HC1 (pH 8.45), 0.1% (w/v) SDS, and 
1 mM thioglycolic acid for 16 h at 100 V and 4°C. During electropho- 
resis and blotting onto PVDF membranes 1 mM thioglycolic acid was 
present in all buffers. The blot was extensively washed with water and 
stained with 0.2% (w/v) Ponceau S in 10% (v/v) acetic acid. The elF-1 
band and a similar sized membrane piece without protein were excised, 
destained for one minute with 0.2 mM NaOH, 20% (v/v) acetonitrile, 
rinsed extensively with water and then cut into squares of approxi- 
mately 1 mm z prior to elution. 
2.3. Preparative lution of elF-1 
Membrane-bound elF-1 was eluted by incubating the PVDF pieces 
in 25 pl of 50 mM Tris-HCl (pH 8.8), containing 2% (w/v) SDS and 1% 
(v/v) hydrogenated Triton X-100 for 16 h at room temperature [10,11]. 
After centrifugation, the supernatant was transferred to another vial 
and pooled with consecutive washes of the membrane pieces with 100 
mM Tris-HC1 (pH 7.6), 1% (v/v) hydrogenated Triton X-100 to a final 
volume of 200 pl. Most of the SDS was removed by repeated extraction, 
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without acidification of the sample with 400,ul heptane/isoamyl alcohol 
4:1 (v/v), saturated with 100 mM Tris-HCl (pH 8.0) [12]. The PVDF 
membrane pieces without protein were treated similarly. 
2.4. Enzymatic digestion of eIF-1 
Endoproteinase Asp-N was added at an enzyme-substrate ratio of 
1/20 (w/w), followed by incubation at 37°C for 24 h. The sample con- 
taining no protein was treated identically. To remove residual SDS 
prior to reversed phase chromatography, the digested samples were 
acidified to 5% (v/v) trifluoroacetic acid and extracted with 400/ll of 
heptane/isoamyl alcohol, saturated with 5% trifluoroacetic acid [12]. 
This step was repeated three times. The samples were then lyophilized 
and dissolved in 50 ktl of 0.1% (v/v) trifluoroacetic acid. 
2.5. Purification of peptides by reversed phase chromatography 
Peptide isolation was performed with the SMART TM system (Phar- 
macia LKB). Digested samples (50 ~tl) were applied to a reversed phase 
C2/C18 precision column 3.2/3 (0.24 ml gel volume) equilibrated with 
0.1% (v/v) trifluoroacetic a id, using a flow rate of 300 ,ul/min at room 
temperature. A linear gradient of acetonitrile (0 50% in 24 rain) con- 
taining 0.1% (v/v) trifluoroacetic acid was used to elute the peptides. 
The column eluants were monitored for absorbance at 214 nm, frac- 
tions of 75 pl were collected and aliquots from individual fractions of 
interest were analyzed for amino acid sequence. 
2.6. Peptide sequencing 
Samples to be subjected to automatic amino acid sequencing were 
lyophilized, dissolved in 15 pl 1% (v/v) trifluoroacetic a id and spotted 
onto Biobrene treated glass fiber filters. The samples were analyzed 
using a Model 476A gas-phase protein microsequencer with an on line 
120A PTH analyzer (Applied Biosystems, Inc.). Chemicals for sequenc- 
ing and analysis of data were as described by the manufacturer. 
3. Results and discussion 
eIF-1 isolated from ribosomal washes was over 90% pure. 
The elF-1 preparation isolated with FPLC techniques from 
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Fig. 1. Gel analysis of purified elF-1. Ribosomal elF-I (0.3/tg, lane 1) 
and elF-1 purified from post-ribosomal supernatant (2,ug, lane 2) were 
analyzed by 13.5% SDS-polyacrylamide g lelectrophoresis and Fast 
Green staining. The molecular mass of marker proteins is indicated on 
the left. The 12,327 Da marker protein is bovine heart cytochrome c,
co-migrating with eIF-1. 
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Fig. 2. Met-tRNA binding to the 40S initiation complex. Binding of 
[~SS]Met-tRNA to 40S subunits was done as described in Methods. 
Sedimentation was from right to left. Minus eIF-l: - - - - ,  with 30 ng of 
ribosomal eIF-1: ---, with about 70 ng of eIF-l, purified as described 
in the text: - ~ . 
postribosomal supernatants was contaminated to 40% with 
other proteins, as can be seen from the stained SDS-poly- 
acrylamide gel (Fig. 1). Both preparations promoted the bind- 
ing of 35S-methionyl-tRNA to 40 S initiation complexes to a 
similar extent (Fig. 2). After blotting, the membrane piece con- 
taining pure eIF-1 was used for sequencing. 
Precautions were taken during electrophoresis and blotting 
against inadvertently blocking of the N-terminus of the protein 
[13]. Nevertheless, in spite of these precautions initial sequence 
efforts performed on eIF-I preparations were unsuccessful, 
indicative of a blocked N-terminus. 
In order to cleave eIF-1 with endoproteinases, the protein 
had to be eluted from the PVDF membrane. The procedure 
described by Fernandez et al. [10] had to be modified by the 
addition of 2% SDS, which was subsequently removed prior to 
proteolytical scission. 
Endoproteinase Glu-C only attained cleavage of 40% of eIF- 
1, while endoproteinase Arg-C did not digest eIF-1 at all. The 
low activity of both enzymes was probably due to residual 
amounts of SDS, present in the eIF-1 sample. However, the 
endoproteinase Asp-N cleaved more than 90% of the starting 
material. The Asp-N protease digest of elF-1 was used for 
sequencing. This endoproteinase cleaves N-terminally of aspar- 
tic and cysteic acid but not of reduced cysteine. 
The generated eIF-I peptides were separated by reversed 
phase chromatography (Fig. 3). No detectable amounts of ma- 
teria[ eluted after a retention time of 12 min, even after doubling 
the percentage of acetonitrile. The asterisk-tagged peaks con- 
tained non-proteineous material. The eluates of three well-re- 
solved peptides were lyophilized and subjected to Edman deg- 
radation employing a gas-phase protein microsequencer. The 
sequences of these three peptides were: 
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Fig. 3. Peptide analysis of protease-cleaved lF-1. Separation ofpeptides, obtained after Asp-N protease cleavage of eIF-1, was done with the SMART 
system (LKB/Pharmacia). The amino acid sequence of the peptides and the absorbance units corrected for background signal of membrane without 
protein, is indicated. Protein sequence analysis of the asterisk-tagged peaks did not give any results. 
(1) Asp-Asp-Leu-Leu-Pro-Ala-Gly-Thr-Glu (DDLLPAGTE), 
(2) Glu-VaMle-Gln-Leu-Gln-Gly (EVIQLQG) and 
(3) Asp-Pro-Phe-Ala (DPFA). 
Peptides 2 and 3 started with an Asp-residue as expected, and 
peptide 1 with a Glu-residue, which was quite surprising, but 
not without precedent when using large amounts of protease 
or long incubation times [14]. The sequence of peptides 2 and 
3 were present in the EMBL database and corresponded to 
amino acid sequences 76 to 82 and 10 to 13 respectively, of the 
SUI1 gene product of the yeast Saccharomyces cerevisiae [5]. 
The valine residue (position 77 in SUI1) in the sequence 
EVIQLQG is an isoleucine in SUI1. The amino acid sequence 
of peptide 1 was identical to the positions 20 to 28 of the 
mammalian isolog of the SUI1 gene product as identified by 
assembling expressed sequence tags [15]. According to the au- 
thors the human SUI11SOI gene product is highly similar to 
proteins from yeast, rice, mosquito and Methanococcus, ug- 
gesting that they all function as initiation factors [15]. 
Yoon and Donahue recognized the SUII protein as a trans- 
lation initiation factor and reasoned it to be the putative yeast 
equivalent of mammalian eIF-1 or eIF-1A, or an initiation 
factor not yet identified by biochemical studies [5]. Later the 
sequence of eIF- IA was solved and found to be dissimilar to 
SUII [61. 
The lack of cleavage by CNBr [16] or BNPS-skatol [17] (re- 
sults not shown) is explained by the lack of methionine and 
tryptophan residues. The NH2-terminal methionine isprobably 
cleaved from the protein, as serine is the second residue. 
Methionine removal and blockade of the serine residue is com- 
mon [18]. The number of amino acid residues in human eIF-1, 
excluding the aminoterminal methionine is 112, making a calcu- 
lated molecular mass of 12,603. 
The sequence around the initiation codon is conserved be- 
tween rice, yeast, and human: CGT ATG T. In spite of the 
absence of the essential A or G at -3,  and the G at +1 [19], the 
rice homolog GOS2 is expressed at high levels [20]. Apparently, 
expression is mainly regulated at the transcriptional level. 
The amino acid sequences of the three isolated peptides, 
spaced over a major part of the protein, irrevocably prove the 
yeast SUI 1 function to be identical to that of rabbit reticulocyte 
eIF-1 and to human SUIIISO1 gene products. 
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